GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.70
Bid: 52.40
Ask: 53.00
Change: 0.70 (1.35%)
Spread: 0.60 (1.145%)
Open: 52.50
High: 52.70
Low: 52.50
Prev. Close: 52.00
GCL Live PriceLast checked at -
Geiger Counter is an Investment Trust

To deliver attractive returns to shareholders principally in the form of capital growth, through investment in companies involved in the exploration, development and production of uranium to supply the nuclear power industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of outstanding Subscription Share Rights

6 May 2022 12:25

RNS Number : 6455K
Geiger Counter Ltd
06 May 2022
 

6 May 2022

GEIGER COUNTER LIMITED(THE "COMPANY")

 

Exercise of outstanding Subscription Share Rights

Geiger Counter Limited announces that further to the announcement on 5 May 2022, the Subscription Trustee has exercised all of the 4,474,044 outstanding Subscription Rights (the "Rump"). The ordinary shares of no par value in the capital of the Company ("Ordinary Shares") that arose from the exercise of the Rump have been sold by finnCap Limited by way of a secondary market placing, raising total net proceeds for the Company of £1.69 million. After deduction of the cost of exercising the Subscription Rights of the Rump and all the costs and expenses of the Subscription Trustee, the Registrar and the secondary market placing, any resultant net proceeds will be distributed by the Registrar to the holders of the Rump in proportion to their Shareholding on the Record Date by 31 May 2022.

Following the exercise of all Subscription Rights, the Company has raised a total of £6.73 million resulting in the net assets of the Company now exceeding £70 million. The funds raised will be invested in a manner consistent with the stated investment objectives of the Company.

Accordingly, the Company announces that it will be issuing and allotting a further 4,474,044 Ordinary Shares, pertaining to the outstanding Subscription Rights exercised by the Subscription Trustee, subject to admission to trading. Application will be made for the new Ordinary Shares to be admitted to trading on TISE and dealings on LSE SETSqx. It is expected that dealings in the new Ordinary Shares will commence at 8.00 a.m. on 10 May 2022.

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), following Admission the issued ordinary share capital of the Company will consist of 133,853,153 Ordinary Shares with voting rights attached. The Company does not hold any shares in treasury. This figure of 133,853,153 Ordinary Shares may be used by the Company's shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the DTRs.

 

The information contained within this RNS is considered to be inside information prior to its release.

For further information, please contact:

CQS (UK) LLP

Craig Cleland

 

+44 (0) 20 7201 5368

finnCap Limited

William Marle / Milesh Hindocha - Corporate Finance

 

+44 (0) 20 7220 0500

Mark Whitfeld / Pauline Tribe - Sales

+44 (0) 20 7220 0500

R&H Fund Services (Jersey) Limited

Jane De Barros-Sousa

+44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGGKMVDGZZM
Date   Source Headline
20th Feb 20241:55 pmRNSNet Asset Value(s)
20th Feb 202412:00 pmRNSShare Buyback
19th Feb 20243:00 pmRNSNet Asset Value(s)
19th Feb 202411:00 amRNSShare Buyback
16th Feb 20241:30 pmRNSNet Asset Value(s)
16th Feb 202412:00 pmRNSShare Buyback
15th Feb 202412:35 pmRNSNet Asset Value(s)
15th Feb 202411:00 amRNSShare Buyback
14th Feb 20242:05 pmRNSNet Asset Value(s)
14th Feb 20241:30 pmRNSShare Buyback
13th Feb 20241:25 pmRNSNet Asset Value(s)
13th Feb 202410:30 amRNSShare Buyback
9th Feb 20241:45 pmRNSNet Asset Value(s)
8th Feb 20243:30 pmRNSPotential listing on the London Stock Exchange
8th Feb 20243:05 pmRNSNet Asset Value(s)
7th Feb 20242:00 pmRNSNet Asset Value(s)
6th Feb 20242:15 pmRNSNet Asset Value(s)
5th Feb 20242:45 pmRNSNet Asset Value(s)
2nd Feb 20243:55 pmRNSNet Asset Value(s)
1st Feb 20243:45 pmRNSNet Asset Value(s)
31st Jan 202412:20 pmRNSNet Asset Value(s)
30th Jan 20242:00 pmRNSNet Asset Value(s)
29th Jan 20243:05 pmRNSNet Asset Value(s)
26th Jan 202412:25 pmRNSNet Asset Value(s)
25th Jan 202412:45 pmRNSNet Asset Value(s)
24th Jan 202412:50 pmRNSNet Asset Value(s)
24th Jan 202410:15 amRNSMonthly factsheet December 2023
23rd Jan 20244:25 pmRNSNet Asset Value(s)
22nd Jan 20243:45 pmRNSNet Asset Value(s)
19th Jan 20241:15 pmRNSNet Asset Value(s)
18th Jan 20241:45 pmRNSNet Asset Value(s)
17th Jan 20241:05 pmRNSNet Asset Value(s)
16th Jan 202412:30 pmRNSNet Asset Value(s)
15th Jan 20241:10 pmRNSNet Asset Value(s)
12th Jan 202412:45 pmRNSNet Asset Value(s)
11th Jan 20241:45 pmRNSNet Asset Value(s)
10th Jan 20241:45 pmRNSNet Asset Value(s)
9th Jan 20242:00 pmRNSNet Asset Value(s)
8th Jan 20243:30 pmRNSNet Asset Value(s)
5th Jan 20244:00 pmRNSNet Asset Value(s)
4th Jan 20243:05 pmRNSNet Asset Value(s)
3rd Jan 20243:20 pmRNSNet Asset Value(s)
29th Dec 20231:30 pmRNSNet Asset Value(s)
28th Dec 20233:20 pmRNSNet Asset Value(s)
27th Dec 20234:00 pmRNSNet Asset Value(s)
27th Dec 20234:00 pmRNSAnnual Financial Report - 30 September 2023
27th Dec 202311:15 amRNSMonthly Factsheet: November 2023
22nd Dec 202312:40 pmRNSNet Asset Value(s)
21st Dec 20233:50 pmRNSNet Asset Value(s)
20th Dec 20233:50 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.